Inhibrx Biosciences, Inc. (INBX)

Inhibrx Biosciences Statistics

Total Valuation

INBX has a market cap or net worth of $530.09 million. The enterprise value is $450.32 million.

Market Cap	530.09M
Enterprise Value	450.32M

Important Dates

The next estimated earnings date is Thursday, November 13, 2025, after market close.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

INBX has 14.49 million shares outstanding. The number of shares has increased by 13.93% in one year.

Current Share Class	14.49M
Shares Outstanding	14.49M
Shares Change (YoY)	+13.93%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	19.01%
Owned by Institutions (%)	45.20%
Float	8.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	378.64
Forward PS	n/a
PB Ratio	7.73
P/TBV Ratio	7.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	321.65
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.98, with a Debt / Equity ratio of 1.56.

Current Ratio	4.98
Quick Ratio	4.82
Debt / Equity	1.56
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-16.97

Financial Efficiency

Return on equity (ROE) is -113.71% and return on invested capital (ROIC) is -31.17%.

Return on Equity (ROE)	-113.71%
Return on Assets (ROA)	-26.29%
Return on Invested Capital (ROIC)	-31.17%
Return on Capital Employed (ROCE)	-57.14%
Revenue Per Employee	$8,696
Profits Per Employee	-$1.02M
Employee Count	161
Asset Turnover	0.01
Inventory Turnover	46.73

Taxes

In the past 12 months, INBX has paid $2,000 in taxes.

Income Tax	2,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +132.50% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+132.50%
50-Day Moving Average	28.64
200-Day Moving Average	18.19
Relative Strength Index (RSI)	68.08
Average Volume (20 Days)	164,896

Short Selling Information

The latest short interest is 524,531, so 3.62% of the outstanding shares have been sold short.

Short Interest	524,531
Short Previous Month	721,500
Short % of Shares Out	3.62%
Short % of Float	6.43%
Short Ratio (days to cover)	6.46

Income Statement

In the last 12 months, INBX had revenue of $1.40 million and -$163.69 million in losses. Loss per share was -$10.58.

Revenue	1.40M
Gross Profit	-171.77M
Operating Income	-98.95M
Pretax Income	-163.69M
Net Income	-163.69M
EBITDA	-96.17M
EBIT	-98.95M
Loss Per Share	-$10.58

Balance Sheet

The company has $186.57 million in cash and $106.79 million in debt, giving a net cash position of $79.78 million or $5.51 per share.

Cash & Cash Equivalents	186.57M
Total Debt	106.79M
Net Cash	79.78M
Net Cash Per Share	$5.51
Equity (Book Value)	68.56M
Book Value Per Share	4.74
Working Capital	155.03M

Cash Flow

In the last 12 months, operating cash flow was -$139.85 million and capital expenditures -$284,000, giving a free cash flow of -$140.13 million.

Operating Cash Flow	-139.85M
Capital Expenditures	-284,000
Free Cash Flow	-140.13M
FCF Per Share	-$9.67

Margins

Gross Margin	n/a
Operating Margin	-7,068.14%
Pretax Margin	-11,692.29%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

INBX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.93%
Shareholder Yield	-13.93%
Earnings Yield	-30.88%
FCF Yield	-26.44%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	Hold
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

INBX has an Altman Z-Score of -0.99 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.99
Piotroski F-Score	1